Law360, New York (October 5, 2016, 4:19 PM EDT) -- The Judicial Panel on Multidistrict Litigation on Tuesday centralized nine lawsuits alleging Johnson & Johnson’s talcum powder products, including Johnson’s Baby Powder, cause ovarian and uterine cancer in New Jersey federal court, where the company is headquartered.
New Jersey will be the easiest location for witnesses based at the headquarters and U.S. District Judge Freda L. Wolfson will be especially efficient, as she is already handling the most advanced case in the MDL, the panel said. Plaintiffs, including individuals who used the powder and developed cancer or their decedents, had asked for the case to be centralized in Illinois, Louisiana, Mississippi,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!